Following earnings, Wells Fargo raised its price target for Eli Lilly (LLY) to $1330. Kevin Horner looks at the past 90 trading days and sees a "well defined uptrend" in LLY's chart. He notes a range between $1095 to $1235 with shares clearing the $1110 level as prior resistance. He believes that could act as a new support level for traders to monitor.